• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchVeru
    Picture of Veru logo

    VERU — Veru News Story

    $2.240.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapMomentum Trap
    • Market Cap
      $38.19m
    • Enterprise Value
      $12.40m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • VERU Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    VERU Dividends
    All News

    Brief: Veru Q2 Revenue USD 4.1 Million

    Picture of Veru logoVeru
    08/05/2024 11:30
    May 08 (Reuters) - Veru Q2 gross profit USD 700 thousand.
    * Q2 net income USD -10 million
    

    Recent news on Veru

    See all news
    • US STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture

      14/10/2026 18:43
    • US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons

      14/10/2026 16:55
    • US STOCKS ON THE MOVE-Albertsons, GlobalFoundries, American Electric Power, Fastenal

      14/10/2026 13:57
    • Oppenheimer upbeat on Veru, says 'come for the lean mass, stay for the muscle function'

      14/10/2026 12:53
    • Veru Inc. reports results for the quarter ended June 30 - Earnings Summary

      10/08/2026 14:31

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.